期刊文献+

喉鳞状细胞癌p16和增殖细胞核抗原表达 被引量:3

Expression of p16 and PCNA in laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨p16基因及增殖细胞核抗原(proliferatingcellnuclearantigen,PCNA)在喉鳞状细胞癌中的表达及其临床意义。方法应用免疫组织化学技术SP法检测抑癌基因p16蛋白及PCNA在40例喉鳞状细胞癌中的表达,并与癌旁组织和正常喉组织对比,结合喉鳞状细胞癌的临床病理特征进行分析。结果在喉鳞状细胞癌中p16阳性率(50.0%)明显低于癌旁组织(76.0%)和正常组织(100.0%,P<0.05);Ⅰ、Ⅱ期喉癌中p16阳性率明显高于Ⅲ、Ⅳ期。喉鳞状细胞癌中PCNA阳性率为55.0%,明显高于癌旁组织(32.0%)和正常组织(10.0%,P<0.05);Ⅰ、Ⅱ期喉鳞状细胞癌中PCNA表达明显低于Ⅲ、Ⅳ期(P<0.05)。p16阳性与阴性患者生存期≥5年的比率分别为66.7%和33.3%,P<0.05;PCNA阳性与阴性患者生存期≥5年的比率分别为37.5%和62.5%,P<0.05。结论p16和PCNA分别是喉鳞状细胞癌进展及预后判断的独立指标;p16和PCNA联合检测对喉鳞状细胞癌的预后评估可能更有价值。 OBJECTIVE To study of the expres- sion and its clinical significance of p16 and proliferatingcell nuclear antigen(PCNA) in laryngeal squamous cellcarcinoma (LSCC). METHODS The expression of p16and PCNA were detected using immunohistochemistrymethod in tumor tissues of 40 patients with laryngealsquamous cell carcinoma. Their results were comparedto that in adjacent of cancer and normal tissues.RESULTS The positive expression rate of p16 in LSCCtissues was 50.0 % which was significantly lowerthan that in adjacent tissues (76.0 % ) and nor-mal tissues(100.0 %,P < 0.05).The positive ex-pression rate of p16 in LSCC tissues of patients withpTNM Ⅰ,Ⅱ stages was significantly higher than that ofpatients with pTNM Ⅲ,Ⅳ stages(P < 0.05).The posi-tive expression rate of PCNA in LSCC tissues was 55.0%which was significantly higher than that in adjacent tis-sues (32.0 %) and normal tissues(10.0 %)(P < 0.05).The positive expression rate of PCNA in LSCC tissuesof patients with pTNM Ⅰ,Ⅱ stages was lower than thatof patients with pTNM Ⅲ,Ⅳ stages(P < 0.05). The sur-vival times ≥ 5 years of patients with p16 positive andp16 negative was 66.7 % and 33.3 % respectively(P <0.05). The survival times ≥ 5 years of patients withPCNA positive and PCNA negative was 37.5 % and 62.5 %respectively(P < 0.05). CONCLUSION p16 and PCNA wereindependent markers of progression and prognosis of pa-tients with LSCC. The p16 and PCNA detected together maybe more helpful to predict the prognosis of patients with LSCC.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2005年第6期347-349,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
  • 相关文献

参考文献8

  • 1Serrano M, Hannon G J, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.Nature, 1993, 366:704-707.
  • 2Wakui S, Furusata M, Itoh T, et al. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis:a morphometric study.J Pathol, 1992, 168:257-262.
  • 3Reed JA, Loganzo F Jr, Shea CR, et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.Cancer Res, 1995, 55:2713-2718.
  • 4Reed AL, Califano J, Cairns P, et al. High frequency of p16(CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res, 1996, 56:3630-3633.
  • 5于刚,关宏程,王琰.P^(16)抑癌基因与喉癌颈淋巴结转移和恶性度关系的探讨[J].耳鼻咽喉(头颈外科),2000,7(4):229-232. 被引量:2
  • 6Kratzke RA, Greatens TM, Rubins JB, et al. Rband p161NK4a expression in resected non-small cell lung tumors. Cancer Res, 1996, 56:3415-3420.
  • 7Hsu JW, Hsu SL, Chu JJ,et al. Increased NM23: MTS1 ratio inversely correlated with metastasis behaviour in human lung squamous cell carcinoma. Anticancer Res, 1997, 17:407-411.
  • 8Zhao R, Hirano M, Kurita S. Expression of proliferating cell nuclear antigen in premalignant lesions of the larynx.Am J Otolaryngol, 1996, 17:36-44.

共引文献1

同被引文献32

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部